Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Biochemical and Biophysical Research Communications|April 3, 2022
Siglec-7 mediates varicella-zoster virus infection by associating with glycoprotein BTadahiro Suenaga, Yasuko Mori, Tatsuo Suzutani, et al.
Microbiology and Immunology|July 22, 2014
Engineering large viral DNA genomes using the CRISPR-Cas9 systemTadahiro Suenaga, Masako Kohyama, Kouyuki Hirayasu, et al.
Biochemical and Biophysical Research Communications|May 8, 2022
Regulation of Siglec-7-mediated varicella-zoster virus infection of primary monocytes by cis-ligandsTadahiro Suenaga, Yasuko Mori, Tatsuo Suzutani, et al.
Journal of Virology|July 26, 2013
Herpesvirus 6 glycoproteins B (gB), gH, gL, and gQ are necessary and sufficient for cell-to-cell fusionYuki Tanaka, Tadahiro Suenaga, Misako Matsumoto, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
Myelin-associated glycoprotein mediates membrane fusion and entry of neurotropic herpesvirusesTadahiro Suenaga, Takeshi Satoh, Pranee Somboonthum, et al.
International Immunology|February 6, 2019
FcγRIIIA-mediated activation of NK cells by IgG heavy chain complexed with MHC class II moleculesYuta Shimizu, Masako Kohyama, Hideki Yorifuji, et al.
Biochemical and Biophysical Research Communications|November 19, 2020
A TCR-like antibody against a proinsulin-containing fusion peptide ameliorates type 1 diabetes in NOD miceYushi Matsumoto, Kazuki Kishida, Maki Matsumoto, et al.
Antimicrobial Agents and Chemotherapy|July 6, 2021
Characteristics of Helicase-Primase Inhibitor Amenamevir-Resistant Herpes Simplex VirusYuko Sato, Tadahiro Suenaga, Makoto Kobayashi, et al.
Biochemical and Biophysical Research Communications|December 28, 2018
Invariant chain p41 mediates production of soluble MHC class II moleculesTatsuya Shishido, Masako Kohyama, Wataru Nakai, et al.
Journal of Virology|August 6, 2010
A single-amino-acid substitution in herpes simplex virus 1 envelope glycoprotein B at a site required for binding to the paired immunoglobulin-like type 2 receptor alpha (PILRalpha) abrogates PILRalpha-dependent viral entry and reduces pathogenesisJun Arii, Jing Wang, Tomomi Morimoto, et al.
Pageof 4